Business Update
Millennium and Ortho Biotech enter U.S. agreement to promote bortezomib for injection
Published in Medical Letter on the CDC and FDA, November 26th, 2006
Under the terms of the agreement, Ortho Biotech will join Millennium in the first quarter of 2007 to promote Velcade to U.S.-based physicians who treat multiple myeloma patients who have received at least one prior therapy. The Ortho Biotech sales force will dedicate a pre-specified amount of effort selling Velcade and Millennium will pay a percentage of the Velcade-related costs for the Ortho Biotech sales...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
More Articles from Medical Letter on the CDC and FDA
- Head & Neck Cancer
U.S. FDA approves new treatment for advanced head and neck cancer - FDA
Scientists at Tokyo Women's Medical University, Department of Dermatology release new data on FDA - Allergy & Immunology
Altana Pharma receives approval to market Ciclesonide nasal spray in the U.S. - Allergy & Immunology
U.S. FDA approves new treatment for allergies - Antibacterial Agents
U.S. Food and Drug Administration issues non-approvable letter to Replidyne for faropenem - Antifungal Agents
Schering-Plough granted U.S. FDA approval of posaconazole for oropharyngeal candidiasis - More from this issue of Medical Letter on the CDC and FDA
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
